2Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med, 2002,165 : 867-903. 被引量：1
3Fagon JY, Chastre J, Hance A J, et al. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med, 1993,94:281-288. 被引量：1
4Rello J, Ollendorf DA, Oster G, et al. Epidemiology and outcomes of pneumonia in a large US database. Chest, 2002,122 : 2115-2121. 被引量：1
5Safdar N, Dezfulian C, Collard HR, et al. Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit Care Med, 2005, 33 : 2184-2193. 被引量：1
6Luna CM, Vujacich P, Niederman MS, et al. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest, 1997, 111: 676-685. 被引量：1
7Horan TC, Gaynes RP. Surveillance of nosocomial infections. In : Hospital Epidemiology and Infection Control, 3rd ed. Mayhall CG, editor. Philadelphia: Lippincott Williams & Wilkins, 2004: 1659-1702. 被引量：1
8Clinical and Laboratory Standards Institute. Performance standards for antimicrohial susceptibility testing; twentieth informational supplement. Vol. 30. Wayne : Pennsylvania( USA. ), 2010 : M100- S19. 被引量：1
9Pach6n-Ib6fiez ME, Jim6nez-Mejias ME, Pichardo C, et al. Activity of tigecycline ( GAR-936 ) against Acinetobacter baumannii strains, including those resistant to imipenem. Antimicrob Agents Chemother, 2004,48:4479-4481. 被引量：1
10American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital- acquired, ventilator-associated, and pneumonia. Am J Respir Crit Care Med, 2005,171:388-416. 被引量：1
1World Health Organization. Review of evidence on health aspects of air pollution-REVIHAAP. [ EB/OL]. [ 2013-03-07 ]. www. euro. who. int/_data/assets/pdf, file/0020/182432/e96762-final, pdf. 被引量：1
